Skip to main content

Table 2 Percentages of cancer screening use (95% confidence interval) by cognitive impairment status among screening-eligible populations

From: The association between cognitive impairment and breast and colorectal cancer screening utilization

Cancer screening   Cognitive impairment p-value
2018
  Overall (n = 5687) Severely impaired
(n = 157)
Mildly impaired (n = 1102) Unimpaired (n = 4428)  
Mammogram 72.9% (71.4–74.3%) 58.3% (48.0–68.6%) 71.6% (68.3–74.8%) 73.7% (72.1–75.4%) = 0.002
  Overall (n = 10,811) Severely impaired
(n = 259)
Mildly impaired (n = 1980) Unimpaired (n = 8572)  
Colonoscopy 60.6% (59.4–61.9%) 63.6% (56.2–70.9%) 61.8% (59.0–64.6%) 60.3% (59.0–61.6%) = 0.436
2019
  Overall (n = 7278) Severely impaired
(n = 140)
Mildly impaired (n = 1305) Unimpaired (n = 5833)  
Mammogram 76.5% (75.3–77.7%) 66.1% (56.6–75.6%) 74.1% (71.2–77.4%) 77.2% (75.9–78.6%) = 0.008
  Overall (n = 13,971) Severely impaired
(n = 271)
Mildly impaired (n = 2358) Unimpaired (n = 11,342)  
Colonoscopy 57.9% (56.8–58.9%) 56.9% (49.3–64.5%) 58.3% (55.6–60.9%) 57.8% (56.7–58.9%) = 0.918